Feature | September 13, 2013| Dave Fornell

Vascular Closure Devices Aid Closure of Large Access Sites

Off-label use of closure devices speeds hemostasis following TEVAR, TAVR and pVAD use

There is no shortage of debate among interventional cardiologists over whether vascular closure devices should be used for standard cath lab procedures. However, some say these devices have a definite niche in areas where they were not originally intended but have found frequent off-label use because of their utility. 

The larger sizes of devices used for transcatheter endovascular aortic repair (TEVAR) and transcatheter aortic valve replacement (TAVR) requires a much larger arteriotomy site than standard percutaneous coronary interventions (PCI). However, these larger holes also make it more difficult to achieve hemostasis using manual compression alone. 

Some of these devices are as large as 24 French, and anything larger requires a surgical cut-down, said Chris Malaisrie, M.D., assistant professor of surgery, division of cardiac surgery, Northwestern University Memorial Hospital, Chicago. “You can’t just hold pressure on a hole that size,” Malaisrie explained. “I use the preclose technique for large bore access for TEVAR and TAVI. I currently use Abbott Prostar or Abbott Perclose Proglide off-label. I prefer the ProGlide, even though you need two of them to close.”

The Abbott Perclose ProGlide suture-mediated closure system provides a suture for vascular closure of 5 – 21 French femoral artery access sites. The vendor says for sheath sizes greater than 8 French, at least two devices and the pre-close technique are required. The system helps reduce time to hemostasis, ambulation and discharge. 

Another off-label application of these devices has been found when using percutaneous ventricular assist devices (pVADs), such as the Abiomed Impella or the CardiacAssist TandemHeart systems. The TandemHeart system uses cannula sizes up to 17 French. 

“We primarily use two ProGlides for Impella 13 French closure using an off-label pre close technique,” said Mladen Vidovich, M.D., FACC, FSCAI, chief, section of cardiology, Jesse Brown VA Medical Center, and associate professor of medicine, University of Illinois, Chicago. 

He said cath labs at both Jesse Brown VA and UIC used closure devices on a regular basis for femoral access PCI in the past to speed patient ambulation and cut nursing time. However, he said both facilities have drastically reduced the need for these devices. 

“Due to our high radial access volume, our closure device use has dwindled, but for the rare groin I’ll use Proglide,” Vidovich said.   

Related Content

TeleHealthRobotics, Tele-Robotic Ultrasound, TRUDI, robotic ultrasound

The Tele-Robotic Ultrasound for Distance Imaging (TRUDI) system uses a robotic arm so a remote sonographer can control the echo probe without the need for them to be in the same room or even be in the hospital during an exam or procedure. 

News | Cardiovascular Ultrasound| June 09, 2016
June 9, 2016 — The American Society of Echocardiography (ASE) will host Echovation Challenge 2016, a competition for
Edwards, Sapien 3, SOURCE 3 Registry, EuroPCR 2016
News | Heart Valve Technology| May 24, 2016
Thirty-day data from the European post-approval study of the Edwards Sapien 3 transcatheter aortic heart valve...
CardiAQ, Neovasc, lawsuit, TMVR
News | Business| May 24, 2016
Edwards Lifesciences Corp. announced that a federal jury in Boston returned a verdict in favor of CardiAQ in a lawsuit...
Mitralign, Series E funding, Trialign, MPAS
News | Heart Valve Technology| May 23, 2016
Mitralign Inc. announced it has raised $39.8 million to date in a Series E equity round of financing.
TAVR outcomes, aortic valve gradient, JACC study
News | Heart Valve Technology| May 23, 2016
Patients with a combination of left ventricular dysfunction and low aortic valve gradient have higher mortality rates...
Direct Flow Medical, TAVR device, DISCOVER trial, three-year results, EuroPCR 2016
News | Heart Valve Technology| May 20, 2016
Direct Flow Medical Inc. presented three-year results from its prospective, multicenter DISCOVER Trial at the EuroPCR...
RDAVR, aortic valve replacement, Edwards Intuity, TRANSFORM Trial, AATS meeting
News | Heart Valve Technology| May 18, 2016
The TRANSFORM trial was designed to evaluate the safety and performance of an investigational rapid deployment aortic...
NeoChord, DS1000 System, FDA approval, U.S. pivotal trial
News | Heart Valve Technology| May 17, 2016
NeoChord Inc. announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug...
4Tech Inc., TriCinch transcatheter tricuspid valve repair device, Jean-Claude Laborde

Image courtesy of 4Tech Inc.

News | Heart Valve Technology| May 16, 2016
4Tech Inc. announced its partnership with Jean-Claude Laborde, M.D., as a research and development (R&D) and...

A Medtronic CoreValve TAVR device being deployed under angiographic image guidance.

 

Feature | Heart Valve Technology| May 16, 2016
 
Overlay Init